SMN1 and proximal spinal muscular atrophy: Although overall expression levels of several microRNAs previously associated with SMA pathology improved after treatment, Welby et al. reported that astrocyte-secreted miR-146a, which modulates PNN-related gene expression, remained elevated in post-treatment CSF samples from SMA type 1/2/3 patients [56].